Allurion Gastric Balloon PAS

Starting soon · Not applicable

Conditions studied: Obesity (BMI>30), Obesity & Overweight

In brief

The primary purpose of this study is to confirm the safety profile results for the Allurion Gastric Balloon System (AGBS).

Key facts

Study ID

NCT07684664

Run by

Allurion Technologies

People needed

250

Starts

2026-07-15

Expected to finish

2029-04-20

Last updated by the study team

2026-07-06

Who can join

Age: 22 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥22 years and ≤ 65 years of age
• BMI ≥30 kg/m2 and ≤ 40 kg/m2
• Have signed study specific Informed Consent Form
• Willing to comply with study requirements, including follow-up visits
• Documented negative pregnancy test in women of childbearing potential
• Women of childbearing potential not intending to become pregnant for the duration of study participation. (Note: Women of childbearing potential must not be nursing at the time of treatment).
• Fully ambulatory without any severe chronic orthopedic disease that requires reliance on crutches, walkers or a wheelchair that could preclude exercise during the study
• At least one unsuccessful attempt at weight loss, such as self-administered, commercial, or medically supervised weight loss program attempted within the 24 months preceding enrollment

You may not qualify if…

• Contra-indications to intragastric balloon placement as outlined in Instructions for Use
• Any conditions that, in the opinion of the Investigator, may render the patient unable to complete the study, or lead to compliance with study requirements, or that might confound study data.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.